Using a highly effective heterologous expression system, the YM-216391 (1) biosynthetic gene cluster was engineered to yield aurantizolicin (2) and the hybrid compound 3. Both of these compounds were isolated and fully structurally characterised and the bioactivity was evaluated. The results indicate that compound 3 exhibits significantly improved antitumor activity.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1039/c8ob02665c | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!